SEC Comment Letter 0000000000-24-011376 to Dare Bioscience, Inc. (DARE) (CIK 0001401914) (DARE)
Dare Bioscience, Inc. (DARE) (CIK 0001401914)
Date: Oct. 8, 2024 · CIK: 0001401914 · Accession: 0000000000-24-011376
AI Filing Summary & Sentiment
File numbers found in text: 001-36395
Letter
October 8, 2024 Sabrina Martucci Johnson Principal Executive Officer and Principal Financial Officer Dare Bioscience, Inc. 3655 Nobel Drive, Suite 260 San Diego, CA 92122 Re:Dare Bioscience, Inc. Form 10-K for the fiscal year ended December 31, 2023 Filed March 28, 2024 File No. 001-36395 Dear Sabrina Martucci Johnson: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
October 8, 2024
Sabrina Martucci Johnson
Principal Executive Officer and Principal Financial Officer
Dare Bioscience, Inc.
3655 Nobel Drive, Suite 260
San Diego, CA 92122
Re:Dare Bioscience, Inc.
Form 10-K for the fiscal year ended December 31, 2023
Filed March 28, 2024
File No. 001-36395
Dear Sabrina Martucci Johnson:
We have completed our review of your filing. We remind you that the company and
its management are responsible for the accuracy and adequacy of their disclosures,
notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences